Kalaiman Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 05-12-2024
- Paid Up Capital ₹ 0.10 M
as on 05-12-2024
- Company Age 34 Year, 26 Days
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 0.16 M
as on 05-12-2024
- Revenue %
(FY 2020)
- Profit 40.91%
(FY 2020)
- Ebitda 42.43%
(FY 2020)
- Net Worth -5.23%
(FY 2020)
- Total Assets -7.50%
(FY 2020)
About Kalaiman Chemicals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.16 M.
Mohamed Mohamed, Mohamed Kader, and Syed Thaiyoub serve as directors at the Company.
- CIN/LLPIN
U24294TN1990PTC020065
- Company No.
020065
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 1990
- Date of AGM
30 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- LocationSecond Street, Pudukottai., Tamil Nadu
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kalaiman Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohamed Mohamed  | Managing Director | 21-Dec-1990 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohamed Kader | Director | 18-Apr-2011 | Current |
| Syed Thaiyoub | Director | 18-Apr-2011 | Current |
Financial Performance of Kalaiman Chemicals.
Kalaiman Chemicals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 40.91% increase in profit. The company's net worth dipped by a decrease of 5.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kalaiman Chemicals?
In 2020, Kalaiman Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mymoon Tobacco Private LimitedActive 10 years 10 monthsMohamed Mohamed and Mohamed Kader are mutual person
- S.M. Mohamed Ibrahim & Company Private LimitedActive 21 years 3 months
Mohamed Mohamed, Mohamed Kader and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Investment Trust Of India Ltd. Creation Date: 22 Feb 1993 | ₹0.16 M | Open |
How Many Employees Work at Kalaiman Chemicals?
Unlock and access historical data on people associated with Kalaiman Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kalaiman Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kalaiman Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
